{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:30:03Z","timestamp":1762504203257,"version":"3.37.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD061255"],"award-info":[{"award-number":["HD061255"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,17]]},"DOI":"10.1093\/jpids\/pix110","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T12:07:42Z","timestamp":1513598862000},"page":"e70-e77","source":"Crossref","is-referenced-by-count":2,"title":["Substituting Abacavir for Stavudine in Children Who Are Virally Suppressed Without Lipodystrophy: Randomized Clinical Trial in Johannesburg, South Africa"],"prefix":"10.1093","volume":"7","author":[{"given":"Renate","family":"Strehlau","sequence":"first","affiliation":[{"name":"Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Shiau","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Columbia University"},{"name":"ICAP, Mailman School of Public Health, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Arpadi","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Columbia University"},{"name":"ICAP, Mailman School of Public Health, Columbia University"},{"name":"Department of Biostatistics, Columbia University"},{"name":"Department of Epidemiology, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faeezah","family":"Patel","sequence":"additional","affiliation":[{"name":"Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francoise","family":"Pinillos","sequence":"additional","affiliation":[{"name":"Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yann","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Physicians and Surgeons, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Coovadia","sequence":"additional","affiliation":[{"name":"Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Abrams","sequence":"additional","affiliation":[{"name":"ICAP, Mailman School of Public Health, Columbia University"},{"name":"Department of Biostatistics, Columbia University"},{"name":"Department of Epidemiology, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Gertrude H. Sergievsky Center, Columbia University"},{"name":"ICAP, Mailman School of Public Health, Columbia University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"key\n\t\t\t\t20180817103421_CIT0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(02)00183-4","article-title":"Efficacy of highly active antiretroviral therapy in HIV-1 infected children","volume":"2","author":"van Rossum","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0002","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180817103421_CIT0003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/430714","article-title":"Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand\u2019s National Access to Antiretroviral Program","volume":"41","author":"Puthanakit","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa","volume":"8","author":"Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0005","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180817103421_CIT0006","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(01)06413-3","article-title":"Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study","volume":"358","author":"Fellay","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180817103421_CIT0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(07)61027-7","article-title":"Clinical update: adverse effects of antiretroviral therapy","volume":"370","author":"Calmy","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180817103421_CIT0008","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1592\/phco.21.9.861.34555","article-title":"Lipodystrophy syndrome in children infected with human immunodeficiency virus","volume":"21","author":"Wedekind","year":"2001","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180817103421_CIT0009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1590\/S1413-86702008000400018","article-title":"Lipodystrophic syndrome in children and adolescents infected with the human immunodeficiency virus","volume":"12","author":"Alves","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1592\/phco.19.1.114.30514","article-title":"A review of protease inhibitor-induced hyperglycemia","volume":"19","author":"Kaufman","year":"1999","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180817103421_CIT0011","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180817103421_CIT0012","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/QAD.0b013e3283269dfb","article-title":"Morphologic and metabolic abnormalities in vertically HIV-infected children and youth","volume":"23","author":"Aldrovandi","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180817103421_CIT0013","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180817103421_CIT0014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/met.2008.0096","article-title":"Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease","volume":"7","author":"Anuurad","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"key\n\t\t\t\t20180817103421_CIT0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"volume-title":"Antiretroviral Therapy for HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access: Recommendations for a Public Health Approach","year":"2010","author":"World Health Organization","key":"key\n\t\t\t\t20180817103421_CIT0016"},{"key":"key\n\t\t\t\t20180817103421_CIT0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1473-3099(15)00319-9","article-title":"Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial","volume":"16","author":"Mulenga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0019","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/INF.0b013e31828c3738","article-title":"Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children","volume":"32","author":"Technau","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180817103421_CIT0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/INF.0000000000000222","article-title":"Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis","volume":"33","author":"Technau","year":"2014","journal-title":"Pediatr Infect Dis J"},{"volume-title":"The South African Antiretroviral Treatment Guidelines, Pretoria, South Africa","year":"2010","author":"National Department of Health Republic of South Africa","key":"key\n\t\t\t\t20180817103421_CIT0021"},{"volume-title":"The South African Antiretroviral Treatment Guidelines","year":"2013","author":"National Department of Health Republic of South Africa","key":"key\n\t\t\t\t20180817103421_CIT0022"},{"volume-title":"National Consolidated Guidelines for the Prevention of Mother-to-child Transmission of HIV (PMTCT) and the Management of HIV in Children, Adolescents and Adults","year":"2015","author":"National Department of Health Republic of South Africa","key":"key\n\t\t\t\t20180817103421_CIT0023"},{"key":"key\n\t\t\t\t20180817103421_CIT0024","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2015.13631","article-title":"Efavirenz-based antiretroviral therapy among nevirapine-exposed HIV-infected children in South Africa: a randomized clinical trial","volume":"314","author":"Coovadia","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180817103421_CIT0025","first-page":"36","article-title":"Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity","volume":"8","author":"Nolan","year":"2003","journal-title":"J HIV Ther"},{"author":"World Health Organization","key":"key\n\t\t\t\t20180817103421_CIT0026"},{"key":"key\n\t\t\t\t20180817103421_CIT0027","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ije\/25.6.1162","article-title":"Development and tracking of central patterns of subcutaneous fat in adolescence and adulthood: the Amsterdam Growth and Health Study","volume":"25","author":"van Lenthe","year":"1996","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20180817103421_CIT0028","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ajcn\/76.5.991","article-title":"Bioelectrical impedance analysis models for prediction of total body water and fat-free mass in healthy and HIV-infected children and adolescents","volume":"76","author":"Horlick","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20180817103421_CIT0029","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180817103421_CIT0030","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","article-title":"Relationship between HAART adherence and adipose tissue alterations","volume":"31 Suppl 3","author":"Ammassari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180817103421_CIT0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1473-3099(15)00319-9","article-title":"Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial","volume":"16","author":"Mulenga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0032","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archpedi.156.5.497","article-title":"Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy","volume":"156","author":"Nachman","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t20180817103421_CIT0033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0b013e32834f3507","article-title":"Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy","volume":"26","author":"Curran","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180817103421_CIT0034","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/135965350701200303","article-title":"Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz","volume":"12","author":"Vigan\u00f2","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180817103421_CIT0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180817103421_CIT0036","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/INF.0b013e31823f0e11","article-title":"Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"31","author":"Aurpibul","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180817103421_CIT0037","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","author":"European Paediatric Lipodystrophy Group","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180817103421_CIT0038","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/archdischild-2012-302633","article-title":"Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy","volume":"98","author":"Arpadi","year":"2013","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20180817103421_CIT0039","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/529384","article-title":"Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study","volume":"46","author":"McComsey","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180817103421_CIT0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/135965350701200301","article-title":"The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients","volume":"12","author":"Milinkovic","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180817103421_CIT0041","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAI.0b013e3181648e16","article-title":"Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children","volume":"47","author":"Tassiopoulos","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180817103421_CIT0042","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpem-2012-0005","article-title":"Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease","volume":"25","author":"Dapena","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t20180817103421_CIT0043","first-page":"20","volume-title":"Low-dose stavudine trials: a public health priority for developing countries","author":"Venter","year":"2012"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/7\/3\/e70\/25505914\/pix110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T20:05:54Z","timestamp":1660161954000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/7\/3\/e70\/4823049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,1,24]]},"published-print":{"date-parts":[[2018,8,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/pix110","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"type":"print","value":"2048-7193"},{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,1,24]]}}}